5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 30.40▲ | 30.39▲ | 30.39▲ | 30.44▲ | 30.27▲ |
MA10 | 30.43▲ | 30.44▲ | 30.44▲ | 30.25▲ | 30.07▲ |
MA20 | 29.84▲ | 29.73▲ | 29.73▲ | 30.32▲ | 29.20▲ |
MA50 | 29.17▲ | 29.24▲ | 29.29▲ | 30.05▲ | 29.64▲ |
MA100 | N/A | N/A | N/A | 29.24▲ | 28.01▲ |
MA200 | N/A | N/A | N/A | 29.64▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.028▲ | 0.047▲ | 0.046▲ | 0.020▲ | 0.129▲ |
RSI | 64.337▲ | 63.508▲ | 63.181▲ | 55.179▲ | 56.942▲ |
STOCH | 66.455 | 78.169 | 78.169 | 81.547▲ | 71.669 |
WILL %R | -8.108▲ | -6.228▲ | -6.228▲ | -17.898▲ | -18.097▲ |
CCI | 64.608 | 61.103 | 61.103 | 65.566 | 81.227 |
CDL | $UDI Doji Candlestick Pattern Detected | Set Alert |
Wednesday, August 13, 2025 06:47 AM
Israeli company Nasus Pharma (NYSE: NSRX), which develops powder-based Intranasal specialized treatments, has announced the completion of its IPO, raising $10 million at a company valuation of $75 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 30.457 | 30.457 | 30.457 | 30.457 | 200 |
14/08/25 | 30.54 | 30.603 | 30.54 | 30.603 | 100 |
13/08/25 | 30.646 | 30.646 | 30.646 | 30.646 | 100 |
12/08/25 | 30.36 | 30.382 | 30.36 | 30.382 | 2,500 |
11/08/25 | 30.173 | 30.173 | 30.135 | 30.135 | 600 |
08/08/25 | 30.2376 | 30.2376 | 30.2376 | 30.2376 | 71 |
07/08/25 | 29.967 | 29.967 | 29.967 | 29.967 | 100 |
06/08/25 | 29.9569 | 29.9569 | 29.9569 | 29.9569 | 97 |
05/08/25 | 30.02 | 30.05 | 30.02 | 30.05 | 700 |
04/08/25 | 29.98 | 30.05 | 29.98 | 30.05 | 400 |
|
|
||||
|
|
||||
|
|